Hospital Medicine: Archives

SUMMARY AND COMMENT

Is Venous Thromboembolism a Risk Factor for Arterial Events?

• September 22, 2009
• David Green, MD, PhD
• Oncology and Hematology

Myocardial infarction and stroke were observed in patients with unprovoked pulmonary embolisms.

• Reviewing:
• Klok FA et al., Blood 2009 Aug 20; 114:1484

SUMMARY AND COMMENT

Improving Follow-Up for ED Patients Who Lack Access to Primary Care

• September 18, 2009
• Richard D. Zane, MD, FAAEM
• Emergency Medicine

Scheduling follow-up appointments before ED discharge improved the rate of follow-up among low-income patients without access to primary care, but, most patients did not show up for their appointments.

• Reviewing:
• Chan TC et al., Ann Emerg Med 2009 Aug; 54:279

SUMMARY AND COMMENT

Predicting Mortality in Patients with Severe Acute Pancreatitis

• September 18, 2009
• Stuart Sherman, MD
• Gastroenterology

A simple new scoring system proved both sensitive and specific for mortality. CME

• Reviewing:
• Singh VK et al., Am J Gastroenterol 2009 Apr; 104:966

SUMMARY AND COMMENT

Physician Recommendations to Limit Life Support — What Do Surrogates Want?

• September 17, 2009
• Allan S. Brett, MD
• General Medicine

And when are physicians obligated to offer a recommendation? Interview

• Reviewing:
• White DB et al., Am J Respir Crit Care Med 2009 Aug 15; 180:320

SUMMARY AND COMMENT

Good News and Bad News About 2009 H1N1 Influenza ("Swine Flu")Free

• September 17, 2009
• Abigail Zuger, MD
• General Medicine

Only a minority of stored serum samples in the U.S. contained antibodies against H1N1, but a new vaccine easily elicited them.

• Reviewing:
• Hancock K et al., N Engl J Med 2009 Sep 10 Clark TW et al., N Engl J Med 2009 Sep 10 Greenberg ME et al., N Engl J Med 2009 Sep 10

NEWS IN CONTEXT

H1N1 Update: Oseltamivir Resistance and Antiviral UseFree

• September 16, 2009
• Peggy Sue Weintrub, MD
• Pediatrics and Adolescent Medicine

The CDC reports oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two children who received prophylaxis and provides revised recommendations for antiviral use during the 2009 flu season. CME

• Reviewing:
• Centers for Disease Control and Prevention (CDC)., MMWR Morb Mortal Wkly Rep 2009 Sep 11; 58:969 Centers for Disease Control and Prevention (CDC)., 2009 Sep 8

SUMMARY AND COMMENT

Which Pneumococcal Vaccine for Adults with COPD?

• September 16, 2009
• Neil M. Ampel, MD
• Infectious Diseases

In a small study, serologic responses were generally better with the 7-valent protein-conjugate vaccine than with the currently approved 23-valent polysaccharide vaccine.

• Reviewing:
• Dransfield MT et al., Am J Respir Crit Care Med 2009 Sep 15; 180:499

SUMMARY AND COMMENT

Preexisting Immunity to the 2009 H1N1 Virus

• September 16, 2009
• Larry M. Baddour, MD
• Infectious Diseases

Very few individuals younger than 30 have protective levels of cross-reactive neutralizing antibodies against this virus.

• Reviewing:
• Hancock K et al., N Engl J Med 2009 Sep 10

SUMMARY AND COMMENT

New Hope for HIV Vaccine Development

• September 16, 2009
• Rajesh T. Gandhi, MD
• Infectious Diseases

Using a novel technique, researchers identified antibodies that neutralize a broad array of HIV strains.

• Reviewing:
• Walker LM et al., Science 2009 Sep 3

SUMMARY AND COMMENT

2009 H1N1 Vaccine: Will One Dose Be Enough?Free

• September 16, 2009
• Daniel J. Diekema, MD, MS
• Infectious Diseases

A single 15-µg dose of 2009 H1N1 vaccine, without an adjuvant, produced strong immune responses in 97% of healthy adults.

• Reviewing:
• Greenberg ME et al., N Engl J Med 2009 Sep 10 Neuzil KM., N Engl J Med 2009 Sep 10